ZeinaAhmadNahlehMD

Clinical Trials

• S0511, Goserelin and Anastrozole in Treating Men With Recurrent or Metastatic Breast Cancer Start of enrollment: 2005 Sep 01

  Withdrawn

  Phase 2

• S0800, Nab-Paclitaxel, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer Start of enrollment: 2010 Apr 01

  Completed

  Phase 2

• Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer Start of enrollment: 2011 Jan 15

  Active, not recruiting

  Phase 3

• AUY922 With Lapatinib and Letrozole for ER+ HER2+ Advanced Breast Cancer Start of enrollment: 2011 Jul 01

  Withdrawn

  Phase 1, Phase 2

• A Phase III Study of BKM120 With Fulvestrant in Patients With HR+,HER2-, AI Treated, Locally Advanced or Metastatic Breast Cancer Who Progressed on or After mTORi Start of enrollment: 2012 Oct 03

  Terminated

  Phase 3

• Open-label, Phase II Study of Stomatitis Prevention With a Steroid-based Mouthwash in Post-menopausal Women With Estrogen-receptor-positive (ER+), Human Epidermal Growth Factor Receptor 2 (HER2)- Metastatic or Locally Advanced Breast Cancer Start of enrollment: 2014 May 01

  Completed

  Phase 2

• Neoadjuvant Propanolol in Breast Cancer Start of enrollment: 2015 Sep 01

  Terminated

  Phase 2

• Assessing the Benefit of Art & Music Therapy on Quality of Life in Patients With Breast Cancer Start of enrollment: 2021 Apr 21

  Recruiting

  Not Applicable

  Roles: Principal Investigator, Contact

• Vitamin B12 for Aromatase Inhibitors Associated Musculoskeletal Symptoms in Breast Cancer Start of enrollment: 2021 Aug 12

  Suspended

  Not Applicable

  Roles: Contact, Principal Investigator

• Join now to see all